Sleep Disorders Trial, Recruiting NCT07192042 Sponsor: Taipei Medical University Shuang Ho Hospital Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07192042
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 20 and 70 years old.
  • People who have been diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform disorder, confirmed using a standard diagnostic tool called the MINI 7.0 (Chinese version).
  • People who are in a relatively stable condition at the time of joining, and are able to understand what the study involves and agree to take part in writing. If a person's illness or thinking difficulties make it hard to fully understand, a family member or legal guardian may provide consent on their behalf, with the person confirming their own agreement once their condition improves.

Who may not be able to join:

  • People who are currently using a CPAP machine (a breathing device worn during sleep) for a sleep condition called obstructive sleep apnoea (OSA).
  • People who have another serious condition affecting the brain or nervous system — such as major depression or bipolar disorder — in addition to their schizophrenia spectrum diagnosis.
  • People who have serious physical health conditions, including but not limited to cancer, advanced heart or lung disease, nerve or muscle disorders that severely affect movement or breathing, seizures that are not controlled by treatment, or any condition that prevents sleeping flat on their back.
  • People whose doctors consider them unsuitable for the trial due to their current clinical situation, such as severe agitation, inability to cooperate, or other safety concerns.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886970749758

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Medical University Shuang Ho Hospital
Registry
ClinicalTrials.gov
Start date
9 September 2025
Est. completion
30 April 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Exploring the Prevalence of Obstructive Sleep Apnea (OSA) in Patients with Schizophrenia; Non-invasive Fiber Optic Physiological Monitoring (nFOPT) for respiratory patterns

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov